前立腺がんバイオマーカーの世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Prostate Cancer Biomarker Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-02390 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、前立腺がんバイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。前立腺がんバイオマーカーの種類別市場規模（尿、血、血清）、用途別市場規模（病院、クリニック、がん研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific、MDx Health、Beckman Coulter、QIAGEN、Pfizer、Roche Diagnostics、Sanofi-Aventis、Myriad Genetics ・地域別グローバル市場分析 2015年-2020年 ・前立腺がんバイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・前立腺がんバイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・前立腺がんバイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・前立腺がんバイオマーカーの南米市場（ブラジル、アルゼンチン） ・前立腺がんバイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：尿、血、血清 ・用途別分析：病院、クリニック、がん研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Prostate Cancer Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Prostate Cancer Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Prostate Cancer Biomarker market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Prostate Cancer Biomarker market has been segmented into:
Urine
Blood
Serum

By Application, Prostate Cancer Biomarker has been segmented into:
Hospitals
Clinics
Cancer Institutes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Cancer Biomarker market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostate Cancer Biomarker markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Cancer Biomarker market.

The report offers in-depth assessment of the growth and other aspects of the Prostate Cancer Biomarker market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Prostate Cancer Biomarker Market Share Analysis
Prostate Cancer Biomarker competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Cancer Biomarker sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostate Cancer Biomarker sales, revenue and market share for each player covered in this report.

The major players covered in Prostate Cancer Biomarker are:
Thermo Fisher Scientific
MDx Health
Beckman Coulter
QIAGEN
Pfizer
Roche Diagnostics
Sanofi-Aventis
Myriad Genetics

レポート目次

---

Table of Contents

1 Prostate Cancer Biomarker Market Overview
1.1 Product Overview and Scope of Prostate Cancer Biomarker
1.2 Classification of Prostate Cancer Biomarker by Type
1.2.1 Global Prostate Cancer Biomarker Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Prostate Cancer Biomarker Revenue Market Share by Type in 2019
1.2.3 Urine
1.2.4 Blood
1.2.5 Serum
1.3 Global Prostate Cancer Biomarker Market by Application
1.3.1 Overview: Global Prostate Cancer Biomarker Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Institutes
1.4 Global Prostate Cancer Biomarker Market by Regions
1.4.1 Global Prostate Cancer Biomarker Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Prostate Cancer Biomarker (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Prostate Cancer Biomarker Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Prostate Cancer Biomarker Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prostate Cancer Biomarker Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Prostate Cancer Biomarker Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prostate Cancer Biomarker Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher Scientific SWOT Analysis
2.1.4 Thermo Fisher Scientific Product and Services
2.1.5 Thermo Fisher Scientific Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.2 MDx Health
2.2.1 MDx Health Details
2.2.2 MDx Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MDx Health SWOT Analysis
2.2.4 MDx Health Product and Services
2.2.5 MDx Health Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter SWOT Analysis
2.3.4 Beckman Coulter Product and Services
2.3.5 Beckman Coulter Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 QIAGEN SWOT Analysis
2.4.4 QIAGEN Product and Services
2.4.5 QIAGEN Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche Diagnostics
2.6.1 Roche Diagnostics Details
2.6.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche Diagnostics SWOT Analysis
2.6.4 Roche Diagnostics Product and Services
2.6.5 Roche Diagnostics Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi-Aventis
2.7.1 Sanofi-Aventis Details
2.7.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi-Aventis SWOT Analysis
2.7.4 Sanofi-Aventis Product and Services
2.7.5 Sanofi-Aventis Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Myriad Genetics SWOT Analysis
2.8.4 Myriad Genetics Product and Services
2.8.5 Myriad Genetics Prostate Cancer Biomarker Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Prostate Cancer Biomarker Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate Cancer Biomarker Players Market Share
3.2.2 Top 10 Prostate Cancer Biomarker Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Prostate Cancer Biomarker Revenue and Market Share by Regions
4.2 North America Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
4.3 Europe Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
4.5 South America Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
5 North America Prostate Cancer Biomarker Revenue by Countries
5.1 North America Prostate Cancer Biomarker Revenue by Countries (2015-2020)
5.2 USA Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
5.3 Canada Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
5.4 Mexico Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
6 Europe Prostate Cancer Biomarker Revenue by Countries
6.1 Europe Prostate Cancer Biomarker Revenue by Countries (2015-2020)
6.2 Germany Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
6.3 UK Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
6.4 France Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
6.5 Russia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
6.6 Italy Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Prostate Cancer Biomarker Revenue by Countries
7.1 Asia-Pacific Prostate Cancer Biomarker Revenue by Countries (2015-2020)
7.2 China Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
7.3 Japan Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
7.4 Korea Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
7.5 India Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
8 South America Prostate Cancer Biomarker Revenue by Countries
8.1 South America Prostate Cancer Biomarker Revenue by Countries (2015-2020)
8.2 Brazil Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
8.3 Argentina Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Prostate Cancer Biomarker by Countries
9.1 Middle East & Africa Prostate Cancer Biomarker Revenue by Countries (2015-2020)
9.2 Saudi Arabia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
9.3 UAE Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
9.4 Egypt Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
9.5 South Africa Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Prostate Cancer Biomarker Revenue and Market Share by Type (2015-2020)
10.2 Global Prostate Cancer Biomarker Market Forecast by Type (2019-2024)
10.3 Urine Revenue Growth Rate (2015-2025)
10.4 Blood Revenue Growth Rate (2015-2025)
10.5 Serum Revenue Growth Rate (2015-2025)
11 Global Prostate Cancer Biomarker Market Segment by Application
11.1 Global Prostate Cancer Biomarker Revenue Market Share by Application (2015-2020)
11.2 Prostate Cancer Biomarker Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Cancer Institutes Revenue Growth (2015-2020)
12 Global Prostate Cancer Biomarker Market Size Forecast (2021-2025)
12.1 Global Prostate Cancer Biomarker Market Size Forecast (2021-2025)
12.2 Global Prostate Cancer Biomarker Market Forecast by Regions (2021-2025)
12.3 North America Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
12.4 Europe Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
12.6 South America Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Prostate Cancer Biomarker Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostate Cancer Biomarker by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostate Cancer Biomarker Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Prostate Cancer Biomarker Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 6. Thermo Fisher Scientific Prostate Cancer Biomarker Major Business
Table 7. Thermo Fisher Scientific Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher Scientific SWOT Analysis
Table 9. Thermo Fisher Scientific Prostate Cancer Biomarker Product and Solutions
Table 10. Thermo Fisher Scientific Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. MDx Health Corporate Information, Location and Competitors
Table 12. MDx Health Prostate Cancer Biomarker Major Business
Table 13. MDx Health Prostate Cancer Biomarker Total Revenue (USD Million) (2018-2019)
Table 14. MDx Health SWOT Analysis
Table 15. MDx Health Prostate Cancer Biomarker Product and Solutions
Table 16. MDx Health Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Beckman Coulter Corporate Information, Location and Competitors
Table 18. Beckman Coulter Prostate Cancer Biomarker Major Business
Table 19. Beckman Coulter Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 20. Beckman Coulter SWOT Analysis
Table 21. Beckman Coulter Prostate Cancer Biomarker Product and Solutions
Table 22. Beckman Coulter Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. QIAGEN Corporate Information, Location and Competitors
Table 24. QIAGEN Prostate Cancer Biomarker Major Business
Table 25. QIAGEN Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 26. QIAGEN SWOT Analysis
Table 27. QIAGEN Prostate Cancer Biomarker Product and Solutions
Table 28. QIAGEN Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Prostate Cancer Biomarker Major Business
Table 31. Pfizer Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Prostate Cancer Biomarker Product and Solutions
Table 34. Pfizer Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Diagnostics Corporate Information, Location and Competitors
Table 36. Roche Diagnostics Prostate Cancer Biomarker Major Business
Table 37. Roche Diagnostics Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 38. Roche Diagnostics SWOT Analysis
Table 39. Roche Diagnostics Prostate Cancer Biomarker Product and Solutions
Table 40. Roche Diagnostics Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanofi-Aventis Corporate Information, Location and Competitors
Table 42. Sanofi-Aventis Prostate Cancer Biomarker Major Business
Table 43. Sanofi-Aventis Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 44. Sanofi-Aventis SWOT Analysis
Table 45. Sanofi-Aventis Prostate Cancer Biomarker Product and Solutions
Table 46. Sanofi-Aventis Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Myriad Genetics Corporate Information, Location and Competitors
Table 48. Myriad Genetics Prostate Cancer Biomarker Major Business
Table 49. Myriad Genetics Prostate Cancer Biomarker Total Revenue (USD Million) (2017-2018)
Table 50. Myriad Genetics SWOT Analysis
Table 51. Myriad Genetics Prostate Cancer Biomarker Product and Solutions
Table 52. Myriad Genetics Prostate Cancer Biomarker Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Prostate Cancer Biomarker Revenue (Million USD) by Players (2015-2020)
Table 54. Global Prostate Cancer Biomarker Revenue Share by Players (2015-2020)
Table 55. Global Prostate Cancer Biomarker Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Prostate Cancer Biomarker Revenue Market Share by Regions (2015-2020)
Table 57. North America Prostate Cancer Biomarker Revenue by Countries (2015-2020)
Table 58. North America Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Table 59. Europe Prostate Cancer Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Prostate Cancer Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Prostate Cancer Biomarker Revenue by Countries (2015-2020)
Table 62. South America Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Prostate Cancer Biomarker Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Table 65. Global Prostate Cancer Biomarker Revenue (Million USD) by Type (2015-2020)
Table 66. Global Prostate Cancer Biomarker Revenue Share by Type (2015-2020)
Table 67. Global Prostate Cancer Biomarker Revenue Forecast by Type (2021-2025)
Table 68. Global Prostate Cancer Biomarker Revenue by Application (2015-2020)
Table 69. Global Prostate Cancer Biomarker Revenue Share by Application (2015-2020)
Table 70. Global Prostate Cancer Biomarker Revenue Forecast by Application (2021-2025)
Table 71. Global Prostate Cancer Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Prostate Cancer Biomarker Picture
Figure 2. Global Prostate Cancer Biomarker Revenue Market Share by Type in 2019
Figure 3. Urine Picture
Figure 4. Blood Picture
Figure 5. Serum Picture
Figure 6. Prostate Cancer Biomarker Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Cancer Institutes Picture
Figure 10. Global Prostate Cancer Biomarker Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Prostate Cancer Biomarker Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Prostate Cancer Biomarker Revenue Market Share in 2019
Figure 19. Global Top 10 Players Prostate Cancer Biomarker Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Prostate Cancer Biomarker Revenue Market Share by Regions (2015-2020)
Figure 23. Global Prostate Cancer Biomarker Revenue Market Share by Regions in 2018
Figure 24. North America Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 25. Europe Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 27. South America Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 29. North America Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Figure 30. North America Prostate Cancer Biomarker Revenue Market Share by Countries in 2019
Figure 31. USA Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 32. Canada Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 34. Europe Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Prostate Cancer Biomarker Revenue Market Share by Countries in 2019
Figure 36. Germany Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 37. UK Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 38. France Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 39. Russia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 40. Italy Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Prostate Cancer Biomarker Revenue Market Share by Countries in 2019
Figure 43. China Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 44. Japan Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 45. Korea Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 46. India Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 48. South America Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Figure 49. South America Prostate Cancer Biomarker Revenue Market Share by Countries in 2019
Figure 50. Brazil Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Prostate Cancer Biomarker Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Prostate Cancer Biomarker Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 55. UAE Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Prostate Cancer Biomarker Revenue and Growth Rate (2015-2020)
Figure 58. Global Prostate Cancer Biomarker Revenue Share by Type (2015-2020)
Figure 59. Global Prostate Cancer Biomarker Revenue Share by Type in 2019
Figure 60. Global Prostate Cancer Biomarker Market Share Forecast by Type (2021-2025)
Figure 61. Global Urine Revenue Growth Rate (2015-2020)
Figure 62. Global Blood Revenue Growth Rate (2015-2020)
Figure 63. Global Serum Revenue Growth Rate (2015-2020)
Figure 64. Global Prostate Cancer Biomarker Revenue Share by Application (2015-2020)
Figure 65. Global Prostate Cancer Biomarker Revenue Share by Application in 2019
Figure 66. Global Prostate Cancer Biomarker Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Cancer Institutes Revenue Growth Rate (2015-2020)
Figure 70. Global Prostate Cancer Biomarker Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Prostate Cancer Biomarker Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Prostate Cancer Biomarker Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
Figure 74. Europe Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
Figure 76. South America Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Prostate Cancer Biomarker Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---